QIM
XLRN

Quantitative Investment Management’s Acceleron Pharma XLRN Stock Holding History

Quantitative Investment Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-13,700
Closed -$535K – 987
2018
Q1 		$535K Buy
13,700
+8,600
+169% +$366K 0.01% 646
2017
Q4 		$216K Sell
5,100
-16,600
-76% -$623K ﹤0.01% 718
2017
Q3 		$809K Buy
+21,700
New +$753K 0.01% 576

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Quantitative Investment Management's XLRN Position: Q2 2018 in Review

Quantitative Investment Management sold out of Acceleron Pharma (XLRN) in Q2 2018, closing a stake of 13,700 shares — an estimated $535K sold.

Quantitative Investment Management first reported a position in XLRN in Q3 2017 and held it in 3 quarters. The position peaked at $809K in Q3 2017. 170 funds tracked by Wall St. Rank hold XLRN as of Q2 2018.

  • Quantitative Investment Management reported no remaining Acceleron Pharma position as of Q2 2018 after selling out during the quarter.
  • Quantitative Investment Management sold 13,700 Acceleron Pharma shares in Q2 2018, an estimated $535K.
  • Quantitative Investment Management first reported a position in Acceleron Pharma in Q3 2017 and held it in 3 quarters.
  • Quantitative Investment Management's Acceleron Pharma position peaked at $809K in Q3 2017.
  • 170 funds tracked by Wall St. Rank held Acceleron Pharma as of Q2 2018.

Based on Quantitative Investment Management's 13F filing for Q2 2018, filed 10 Aug 2018.